Gilead Sciences

Significant blow to hopes of identifying existing medicines to treat disease

Acute shortages reported in number of countries because of difficulties with stocks from US

Experimental blend of drugs may suggest US president more ill than medical team admits

Doctor ‘extremely happy’, but source close to president strikes a more negative note

Iseq rises 0.48% on the day, with Ryanair and Aer Lingus owner IAG among travel gainers

Ryanair closes higher on news that British government is to ramp up Covid testing plans

Drugmaker more upbeat on full-year impact after sharp drop in medical visits early in the pandemic

Company to invest €7m as it also establishes paediatric centre of excellence here

EMA committee recommends drug’s use in adults and adolescents from 12 years of age

Markets report: Losses in technology and healthcare stocks halt a recent rally

The pan-European Stoxx 600 declined 0.8 per cent earlier, led lower by personal and household goods

Shares dip as it emerges there are no active talks on what would be politically sensitive deal

Investors back belief economic downturn from Covid-19 pandemic has bottomed out

Company buys vaccine maker Themis and announced collaboration on two vaccines

Group of multinationals in Ireland has worked with academics in the pharma sector

Chinese Embassy in Washington condemned the allegations as ‘lies’

Stillorgan Industrial Estate unit equipped for pharma R&D and medical manufacturing

The Swiss pharma company received the clearance from the US Food and Drug Administration

Trial shows drug ‘has a clear-cut, significant, positive effect in diminishing the time to recovery’

Norway to cut production by 10% as demand shrinks by a third

US president looking at different options in terms of consequences for Beijing over virus

Renewed hopes for Covid-19 treatment boosts investor sentiment

Anti-virals designated for investigation by WHO to be tested on wider international scale

Disappointing results revealed in draft documents published accidentally by WHO

Iseq outperforms European peers and rises 3.83%, with Flutter a standout performer

Iseq index among top performers in Europe

Central banks’ stimulus has driven relentless rebound but it comes at a cost that markets haven’t priced in

US shares rise after leaked report enthused about benefits of remdesivir in 125 Covid-19 patients

Early impressions from US study show severely ill patients in clinical trial recovering quickly

Already many ‘stupid studies being published’ without peer review, says Luke O’Neill

Scientists are focusing on three main drug types

Markets report: Iseq was virtually flat on the day with Ryanair amongst losers

Sterling weakens as investors grow nervous over smooth trade deal post-Brexit

ViiV Healthcare Company and Shionogi & Co are suing Gilead and its Irish subsidiary

Cork-based division of pharma giant reports pretax profits of €130m

Lawsuit claims drugmaker reaped billions of dollars through taxpayer-funded research

Bristol-Myers Squibb’s acquisition of Celgene goes ahead after Amgen pays €13.4bn for drug

China figures lift European markets and ease investor concerns over global slowdown

Irish shares outperform peers with benchmark index rising 0.62%

The move to buy Loxo Oncology is the second multibillion-dollar cancer deal of the year by a major US pharma giant